| 期刊全称 | Tomography | |||||||||||||||||||||||||||||||||||||||
| 期刊缩写 | TOMOGRAPHY | |||||||||||||||||||||||||||||||||||||||
|
涉及主题
（科研通AI识别） |
||||||||||||||||||||||||||||||||||||||||
| 期刊介绍 | TomographyTM publishes basic (technical and pre-clinical) and clinical scientific articles which involve the advancement of imaging technologies. Tomography encompasses studies that use single or multiple imaging modalities including for example CT, US, PET, SPECT, MR and hyperpolarization technologies, as well as optical modalities (i.e. bioluminescence, photoacoustic, endomicroscopy, fiber optic imaging and optical computed tomography) in basic sciences, engineering, preclinical and clinical medicine. Tomography also welcomes studies involving exploration and refinement of contrast mechanisms and image-derived metrics within and across modalities toward the development of novel imaging probes for image-based feedback and intervention. The use of imaging in biology and medicine provides unparalleled opportunities to noninvasively interrogate tissues to obtain real-time dynamic and quantitative information required for diagnosis and response to interventions and to follow evolving pathological conditions. As multi-modal studies and the complexities of imaging technologies themselves are ever increasing to provide advanced information to scientists and clinicians. Tomography provides a unique publication venue allowing investigators the opportunity to more precisely communicate integrated findings related to the diverse and heterogeneous features associated with underlying anatomical, physiological, functional, metabolic and molecular genetic activities of normal and diseased tissue. Thus Tomography publishes peer-reviewed articles which involve the broad use of imaging of any tissue and disease type including both preclinical and clinical investigations. In addition, hardware/software along with chemical and molecular probe advances are welcome as they are deemed to significantly contribute towards the long-term goal of improving the overall impact of imaging on scientific and clinical discovery. | |||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||
| 期刊ISSN | print: 2379-1381on-line: 2379-139X | |||||||||||||||||||||||||||||||||||||||
| 2026最新影响因子 (2026年6月17日发布) 与上一年的差值 |
2.5↑ 0.3 | |||||||||||||||||||||||||||||||||||||||
| 历年影响因子 |
|
|||||||||||||||||||||||||||||||||||||||
| 历年发表/被引量 （科研通AI通过大数据分析） 最后更新日期：2026-08-11 |
|
|||||||||||||||||||||||||||||||||||||||
| h-index（2021） | 暂无h-index数据 | |||||||||||||||||||||||||||||||||||||||
| 自引率 | 9.10% | |||||||||||||||||||||||||||||||||||||||
| 涉及的研究领域 | Medicine-Radiology, Nuclear Medicine and Imaging | |||||||||||||||||||||||||||||||||||||||
| 2026年新锐分区 （2026年3月24日发布） |
|
|||||||||||||||||||||||||||||||||||||||
| 2026年WOS期刊分区 （2026年6月17日发布） |
JCR学科分类
JCI学科分类
|
|||||||||||||||||||||||||||||||||||||||
| 中科院2025年分区 （2025年3月20日发布） |
|
|||||||||||||||||||||||||||||||||||||||
| 中科院2024年分区 （2023年12月27日发布） |
|
|||||||||||||||||||||||||||||||||||||||
| 中科院《国际期刊预警名单（试行）》名单 |
2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 |
|||||||||||||||||||||||||||||||||||||||
| 期刊主页 | ||||||||||||||||||||||||||||||||||||||||
| 投稿网址 | 暂无 | |||||||||||||||||||||||||||||||||||||||
| 编辑部地址 | ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052 | |||||||||||||||||||||||||||||||||||||||
| 出版商 | Grapho Publications LLC | |||||||||||||||||||||||||||||||||||||||
| 出版国家（地区） | UNITED STATES | |||||||||||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||||||||||||||||||||
| 每年出版文章数 | 76 | |||||||||||||||||||||||||||||||||||||||
| Gold OA文章占比 | 99.78% | |||||||||||||||||||||||||||||||||||||||
| 原创研究文献占比 （排除综述） |
90.87% | |||||||||||||||||||||||||||||||||||||||
| SCI收录类型 |
Science Citation Index Expanded (SCIE) Scopus (CiteScore) |
|||||||||||||||||||||||||||||||||||||||
| PubMed链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2379-1381%5BISSN%5D | |||||||||||||||||||||||||||||||||||||||
| 平均审稿周期 | 网友分享经验： |
|||||||||||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： |
|||||||||||||||||||||||||||||||||||||||
| 相关链接 |
LetPub
您可以在上述网站查看该期刊的网友互动，及期刊影响力的其它指标。
|
|||||||||||||||||||||||||||||||||||||||
皖公网安备34019202002308
